Rejoinder: Response-Adaptive Randomization in Clinical Trials
Rejoinder: Response-Adaptive Randomization in Clinical Trials
We are very grateful to the editors of Statistical Science and the discussants for the opportunity to mark the finish line of our paper (Robertson et al., 2023c) with such a high note of clarity and optimism toward the future.Each discussant takes aspects briefly mentioned in our paper and expands …